SANTA CLARA, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
Initial FIH procedures launch FastWave's multi-center feasibility study evaluating the safety and performance of its laser-based coronary IVL platform. MINNEAPOLIS, June 3, 2025 /PRNewswire/ -- ...
SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
At EuroPCR 2026, experts highlighted major advances in the treatment of previously untreatable calcified coronary lesions.
SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular ...
SANTA CLARA, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...
ShockWave Medical, Inc. SWAV is well poised for growth, backed by its research and development (R&D) efforts and focus on clinical studies. Shares of this Zacks Rank #3 (Hold) company have risen 1.4% ...
HACKENSACK, N.J. (CBSNewYork)-- One of the most common heart procedures done in this country is a called a coronary angioplasty. A balloon opens up a heart artery and usually a stent is placed to keep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results